Tyler Reimschisel, MD
- Specialty: Pediatric Neurology, Genetics
-
Primary Location: 11100 Euclid Ave (0 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Cleveland Medical Center Lakeside (0 mi.)
11100 Euclid Ave
Lakeside Ste 1500
Cleveland, OH 44106
UH Rainbow Babies & Children's Hospital (0 mi.)
11100 Euclid Ave
Ste 170
Cleveland, OH 44106
216-844-3691
UH RBC Solon Health Center (12 mi.)
34055 Solon Rd
Ste 200
Solon, OH 44139
216-844-3691
Biography: Tyler Reimschisel, MD
Titles
- Adjunct Professor, CWRU School of Medicine
Certifications & Memberships
- Clinical Biochemical Genetics - American Board of Medical Genetics and Genomics
- Clinical Genetics and Genomics - American Board of Medical Genetics and Genomics
- Neurology with Special Qualifications in Child Neurology - American Board of Psychiatry and Neurology
Education
Residency | Clinical Genetics and Clinical Biochemical Genetics
Clinical Genetics and Clinical Biochemical Genetics - The Johns Hopkins Children's Center (2002 - 2005)
Residency | Child Neurology
Child Neurology - The Johns Hopkins Children's Center (1999 - 2002)
Residency | Pediatrics
Pediatrics - The Johns Hopkins Children's Center (1997 - 1999)
Medical Education
Rush Medical College Of Rush University (1993 - 1997)
Other Education
University Of Illinois At Chicago (2016)
Undergraduate
University Of Chicago (1993)
About
Tyler Reimschisel, MD, is the division chief of Pediatric Neurology and Epilepsy at University Hospitals Rainbow Babies & Children’s Hospital, senior attending physician in the UH Center for Human Genetics, and professor in the Departments of Pediatrics & Genetics and Genome Sciences within the Case Western Reserve University School of Medicine.
As a pediatric neurologist and biochemical geneticist, Dr. Reimschisel’s primary clinical interests include the interprofessional evaluation and management of children, adolescents and adults with inborn metabolic diseases and other genetic conditions that cause neurodevelopmental disabilities, such as global developmental delay, intellectual disability, autism, epilepsy and cerebral palsy. He also provides care to pediatric patients with neurologic conditions, including developmental delay, intellectual disability, autism, seizures and headaches.
Dr. Reimschisel earned his medical degree at Rush Medical College in Chicago and completed residencies in pediatrics, child neurology, clinical genetics and clinical biochemical genetics at Johns Hopkins Hospital in Baltimore. He is board-certified in child neurology, clinical genetics and clinical biochemical genetics.
As a certified coach and the founder of Holistic Teaming, LLC, Dr. Reimschisel provides individual executive and team coaching, team development and team training in clinical, academic, nonprofit, corporate and community settings.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Tyler Reimschisel did not disclose any Outside Relationships with Industry.